Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajeet Gajra

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Adjuvant chemotherapy in older adults with non-small cell lung cancerAjeet Gajra
Journal of Geriatric Oncology|December 21, 2016
Designing geriatric-specific trials in advanced lung cancer: What, who and how to study?Ajeet Gajra
Journal of Geriatric Oncology|March 8, 2016
Assessment of comorbidity in lung cancer: How, why, and in whom?Ajeet Gajra
Cardiovascular & Hematological Agents in Medicinal Chemistry|September 30, 2010
Thromboembolism with immunomodulatory agents in the treatment of multiple myelomaAnurag Singh, Ajeet Gajra
Cardiovascular & Hematological Agents in Medicinal Chemistry|May 8, 2010
Cardiovascular effects of EGFR (epidermal growth factor receptor) monoclonal antibodiesPreeti Chaudhary, Ajeet Gajra
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Non–small-cell lung cancer in elderly patients: a discussion of treatment optionsAjeet Gajra, Aminah Jatoi
The Lancet. Oncology|December 17, 2013
Immunotherapy in non-small-cell lung cancer: a good start?Jeffrey A Bogart, Ajeet Gajra
Advances in Hematology|April 13, 2012
Current status of new anticoagulants in the management of venous thromboembolismRoberto C Montoya, Ajeet Gajra
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Limited-Stage Small-Cell Lung Cancer: An Age Limit for Combined Modality Therapy?Jeffrey A Bogart, Ajeet Gajra
Hospital Practice (1995)|May 18, 2011
Treatment of advanced lung cancer in the elderlyAjeet Gajra, Stuart M Lichtman
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Adjuvant chemotherapy in older adults with non-small cell lung cancerAjeet Gajra
Journal of Geriatric Oncology|December 21, 2016
Designing geriatric-specific trials in advanced lung cancer: What, who and how to study?Ajeet Gajra
Journal of Geriatric Oncology|March 8, 2016
Assessment of comorbidity in lung cancer: How, why, and in whom?Ajeet Gajra
Cardiovascular & Hematological Agents in Medicinal Chemistry|September 30, 2010
Thromboembolism with immunomodulatory agents in the treatment of multiple myelomaAnurag Singh, Ajeet Gajra
Cardiovascular & Hematological Agents in Medicinal Chemistry|May 8, 2010
Cardiovascular effects of EGFR (epidermal growth factor receptor) monoclonal antibodiesPreeti Chaudhary, Ajeet Gajra
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Non–small-cell lung cancer in elderly patients: a discussion of treatment optionsAjeet Gajra, Aminah Jatoi
The Lancet. Oncology|December 17, 2013
Immunotherapy in non-small-cell lung cancer: a good start?Jeffrey A Bogart, Ajeet Gajra
Advances in Hematology|April 13, 2012
Current status of new anticoagulants in the management of venous thromboembolismRoberto C Montoya, Ajeet Gajra
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Limited-Stage Small-Cell Lung Cancer: An Age Limit for Combined Modality Therapy?Jeffrey A Bogart, Ajeet Gajra
Hospital Practice (1995)|May 18, 2011
Treatment of advanced lung cancer in the elderlyAjeet Gajra, Stuart M Lichtman
Pageof 13